Evidence map›Paper›PMID 33354107›Full record

ArticleCancer informatics2017

Identification of Prognostic Genes and Pathways in Lung Adenocarcinoma Using a Bayesian Approach.

Yu Jiang, Yuan Huang, Yinhao Du, Yinjun Zhao, Jie Ren, Shuangge Ma, Cen Wu

Open access · goldAbstract read
In one paragraph

Article in Cancer informatics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Yu JiangDivision of Epidemiology, Biostatistics and Environmental Health, School of Public Health, University of Memphis, Memphis, TN, USA.
Yuan HuangCooperative Studies Program, VA Connecticut Healthcare System, West Haven, CT, USA.
Yinhao DuDepartment of Statistics, Kansas State University, Manhattan, KS, USA.
Yinjun ZhaoDepartment of Biostatistics, Yale University, New Haven, CT, USA.
Jie RenDepartment of Statistics, Kansas State University, Manhattan, KS, USA.
Shuangge MaCooperative Studies Program, VA Connecticut Healthcare System, West Haven, CT, USA.
Cen WuDepartment of Statistics, Kansas State University, Manhattan, KS, USA.
Kansas State University · USYale University · USVA Connecticut Healthcare System · US

Funding

Novel Methods for Integrative Analysis of Cancer Genomic DataR01CA142774 · NCI · YALE UNIVERSITY · PI MA, SHUANGGE · 2010 to 2013
$1.3M
Development of Integrated Analysis Methods and Applications to TCGA dataR03CA182984 · NCI · YALE UNIVERSITY · PI MA, SHUANGGE · 2014 to 2015
$167k
NCI NIH HHS R01 CA142774NCI NIH HHS R03 CA182984
6 · The paper itself

Abstract

Lung cancer is the leading cause of cancer-associated mortality in the United States and the world. Adenocarcinoma, the most common subtype of lung cancer, is generally diagnosed at the late stage with poor prognosis. In the past, extensive effort has been devoted to elucidating lung cancer pathogenesis and pinpointing genes associated with survival outcomes. As the progression of lung cancer is a complex process that involves coordinated actions of functionally associated genes from cancer-related pathways, there is a growing interest in simultaneous identification of both prognostic pathways and important genes within those pathways. In this study, we analyse The Cancer Genome Atlas lung adenocarcinoma data using a Bayesian approach incorporating the pathway information as well as the interconnections among genes. The top 11 pathways have been found to play significant roles in lung adenocarcinoma prognosis, including pathways in mitogen-activated protein kinase signalling, cytokine-cytokine receptor interaction, and ubiquitin-mediated proteolysis. We have also located key gene signatures such as

Indexed as

Bayesian approachcancer prognosislung adenocarcinomapathway analysisTCGA

Identifiers

PMID33354107
PMCPMC7736146
OpenAlexW2592929990

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.